Related Experiment Video
Updated: Nov 12, 2025

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
Published on: June 7, 2019
MiR-125b acts as a tumor suppressor of melanoma by targeting NCAM
1Department of Plastic and Aesthetic Surgery, the Fourth Affiliated Hospital of Harbin Medical University, Harbin, China.
Purpose:
To investigate the effects of micro ribonucleic acid (miR)-125b on the growth and apoptosis of malignant melanoma (MM) cells and related mechanisms.
Methods:
The differences in the expressions of miR-125b and neural cell adhesion molecule-120 (NCAM-120), NCAM-140 and NCAM-180 in 5 cases of MM tissues (MM group) and corresponding adjacent tissues (Paracancer group) as well as MM cells were detected via quantitative real-time polymerase chain reaction (qRT-PCR) and immunohistochemistry, respectively. Next, malignant melanoma A375 cells were selected to exogenously overexpress miR-125 (miR-125 mimic group). Then, in vitro functional assays were conducted to determine the influences of miR-125b on the proliferation, migration and apoptosis of MM cells, and the changes in the binding of miR-125b to the 3'-untranslated region (3'-UTR) of wild-type and mutant NCAM messenger RNAs (mRNAs) were verified using dual-luciferase assay.
Results:
MiR-125b was significantly lowly expressed in MM tissues and cells (p<0.01), while NCAM-120, NCAM-140 and NCAM-180 were clearly highly expressed in MM tissues and cells (p<0.05). After miR-125b was exogenously overexpressed in A375 cells, the proliferation and migration ability of A375 cells was decreased, whereas the proportion of apoptotic cells rose (p<0.05). Besides, the results of dual-luciferase reporter assay revealed that the luciferase activity of A375 cells in the 3'-UTR of wild-type NCAM mRNA was overtly lowered compared with that of mutant NCAM mRNA (p<0.05).
Conclusions:
MiR-125b acts as a tumor suppressor in MM cells by targeting and binding to NCAM.
Insights
MicroRNA-125b (miR-125b) acts as a tumor suppressor in malignant melanoma (MM). Lower miR-125b levels correlate with increased MM cell growth and migration, while targeting neural cell adhesion molecule (NCAM).
Area of Science:
- Molecular Oncology
- Biochemistry
Background:
- Malignant melanoma (MM) is an aggressive skin cancer with complex regulatory mechanisms.
- MicroRNAs (miRNAs) play crucial roles in cancer development and progression.
Purpose of the Study:
- To investigate the role of microRNA-125b (miR-125b) in malignant melanoma (MM) cell growth and apoptosis.
- To elucidate the underlying molecular mechanisms involving neural cell adhesion molecule (NCAM).
Main Methods:
- Quantitative real-time polymerase chain reaction (qRT-PCR) and immunohistochemistry were used to assess miR-125b and NCAM expression in MM tissues and cells.
- Exogenous overexpression of miR-125b in MM A375 cells was performed.
- In vitro functional assays (proliferation, migration, apoptosis) and dual-luciferase reporter assays were conducted.
Main Results:
- MiR-125b was significantly downregulated in MM tissues and cells.
- NCAM isoforms (NCAM-120, NCAM-140, NCAM-180) were significantly upregulated in MM.
- Overexpression of miR-125b inhibited MM cell proliferation and migration while promoting apoptosis.
- MiR-125b directly targets the 3'-untranslated region (3'-UTR) of NCAM mRNA.
Conclusions:
- MiR-125b functions as a tumor suppressor in malignant melanoma.
- The tumor-suppressive effects of miR-125b are mediated through its targeting of NCAM.
Related Concept Videos
MicroRNAs
MicroRNAs
Abnormal Proliferation
Mitogens and the Cell Cycle
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...

